Pfizer's outlook disappoints after Viagra loses patent protection and Lyrica faces same fate

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent protection and pain killer Lyrica faces similar competition from generic drugmakers.

from Health and Science https://cnb.cx/2MCymqJ